Sphingolipids in Apoptosis

Forty years ago, the term “apoptosis” was introduced to describe a form of programmed cell death. Key players that mediate apoptosis at the molecular level such as caspases, death receptors, Bcl-2 family members have since been identified and their regulation remains a research focus of many laborat...

Повний опис

Збережено в:
Бібліографічні деталі
Опубліковано в: :Experimental Oncology
Дата:2012
Автори: Tirodkar, T.S., Voelkel-Johnson, C.
Формат: Стаття
Мова:Англійська
Опубліковано: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2012
Теми:
Онлайн доступ:https://nasplib.isofts.kiev.ua/handle/123456789/139053
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
Назва журналу:Digital Library of Periodicals of National Academy of Sciences of Ukraine
Цитувати:Sphingolipids in Apoptosis / T.S. Tirodkar, C. Voekel-Johnson // Experimental Oncology. — 2012. — Т. 34, № 3. — С. 231-242. — Бібліогр.: 152 назв. — англ.

Репозитарії

Digital Library of Periodicals of National Academy of Sciences of Ukraine
_version_ 1862725970043076608
author Tirodkar, T.S.
Voelkel-Johnson, C.
author_facet Tirodkar, T.S.
Voelkel-Johnson, C.
citation_txt Sphingolipids in Apoptosis / T.S. Tirodkar, C. Voekel-Johnson // Experimental Oncology. — 2012. — Т. 34, № 3. — С. 231-242. — Бібліогр.: 152 назв. — англ.
collection DSpace DC
container_title Experimental Oncology
description Forty years ago, the term “apoptosis” was introduced to describe a form of programmed cell death. Key players that mediate apoptosis at the molecular level such as caspases, death receptors, Bcl-2 family members have since been identified and their regulation remains a research focus of many laboratories. In 1993, approximately 20 years after the introduction of apoptosis, the sphingolipid ceramide was first linked to this form of cell death. Sphingolipids are bioactive components of cellular membranes that are involved in numerous physiological functions. In this paper, we discuss the inherent complexities of sphingolipid signaling and elaborate on how sphingolipids, primarily ceramide, influence apoptotic events such as death receptor aggregation in the plasma membrane and pore formation at the mitochondria. Possible roles of sphingolipids in other subcellular compartments, such as the nucleus, endoplasmic reticulum and lysosomes are also discussed. We conclude by summarizing the recent developments in sphingolipid based cancer therapy. This article is part of a Special Issue entitled “Apoptosis: Four Decades Later”.
first_indexed 2025-12-07T18:55:07Z
format Article
fulltext
id nasplib_isofts_kiev_ua-123456789-139053
institution Digital Library of Periodicals of National Academy of Sciences of Ukraine
issn 1812-9269
language English
last_indexed 2025-12-07T18:55:07Z
publishDate 2012
publisher Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
record_format dspace
spelling Tirodkar, T.S.
Voelkel-Johnson, C.
2018-06-19T18:49:40Z
2018-06-19T18:49:40Z
2012
Sphingolipids in Apoptosis / T.S. Tirodkar, C. Voekel-Johnson // Experimental Oncology. — 2012. — Т. 34, № 3. — С. 231-242. — Бібліогр.: 152 назв. — англ.
1812-9269
https://nasplib.isofts.kiev.ua/handle/123456789/139053
Forty years ago, the term “apoptosis” was introduced to describe a form of programmed cell death. Key players that mediate apoptosis at the molecular level such as caspases, death receptors, Bcl-2 family members have since been identified and their regulation remains a research focus of many laboratories. In 1993, approximately 20 years after the introduction of apoptosis, the sphingolipid ceramide was first linked to this form of cell death. Sphingolipids are bioactive components of cellular membranes that are involved in numerous physiological functions. In this paper, we discuss the inherent complexities of sphingolipid signaling and elaborate on how sphingolipids, primarily ceramide, influence apoptotic events such as death receptor aggregation in the plasma membrane and pore formation at the mitochondria. Possible roles of sphingolipids in other subcellular compartments, such as the nucleus, endoplasmic reticulum and lysosomes are also discussed. We conclude by summarizing the recent developments in sphingolipid based cancer therapy. This article is part of a Special Issue entitled “Apoptosis: Four Decades Later”.
en
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
Experimental Oncology
Reviews
Sphingolipids in Apoptosis
Article
published earlier
spellingShingle Sphingolipids in Apoptosis
Tirodkar, T.S.
Voelkel-Johnson, C.
Reviews
title Sphingolipids in Apoptosis
title_full Sphingolipids in Apoptosis
title_fullStr Sphingolipids in Apoptosis
title_full_unstemmed Sphingolipids in Apoptosis
title_short Sphingolipids in Apoptosis
title_sort sphingolipids in apoptosis
topic Reviews
topic_facet Reviews
url https://nasplib.isofts.kiev.ua/handle/123456789/139053
work_keys_str_mv AT tirodkarts sphingolipidsinapoptosis
AT voelkeljohnsonc sphingolipidsinapoptosis